Trends in Endocrinology & Metabolism
ReviewGhrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
Section snippets
GHS: what is a growth hormone secretagogue?
The field of GHS research grew out of studies conducted on opioid peptides during the 1970s. After the identification of enkephalins as the endogenous ligands for the morphine receptor in 1975, many opioid peptide derivatives were synthesized in an attempt to develop new anodynes that would be more potent and less addictive. In 1976, Cyril Y. Bowers of Tulane University (New Orleans, LA, USA) found that some opioid peptide derivatives had weak GH-releasing activity 7. After this observation,
Purification and identification of ghrelin, an endogenous ligand for the GHS-R
In recent years, searches for novel ligands using orphan GPCR-expressing cells have resulted in the discovery of several novel bioactive peptides, such as nociceptin/orphanin FQ (Refs 17, 18), orexins/hypocretins 19 and prolactin-releasing peptide 20. Indeed, orphan receptors represent important new tools for the discovery of novel bioactive molecules and for use in drug development 21.
Unlike other orphan GPCRs, GHS-R was known to bind artificial ligands, such as GHRP-6 or hexarelin, providing
Characteristics of the structures of ghrelin and its precursor
Ghrelin is the first known example of a bioactive peptide modified by an acyl acid. In fact, modification by n-octanoic acid is an unprecedented mechanism in mammals, although acyl modification has been seen in G proteins and receptors, which are conjugated to myristoyl acid (C14) or palmitoyl acid (C16) 23. Because the n-octanoyl modification of ghrelin is essential for its activity, the enzyme that catalyses the modification step should be important for the regulation of the activity of
Tissue distribution of ghrelin
Rat ghrelin mRNA, as shown by northern blot analysis, is expressed in the stomach. In situ hybridization and immunohistochemical analyses further indicated that ghrelin-containing cells are a distinct endocrine cell type found in the submucosal layer of the stomach. These cells, known as X/A-like cells, contain round, compact, electron-dense granules and are filled with ghrelin 27. Moreover, normal, adult human plasma samples contain 100–120 fmol ghrelin ml−1. These facts indicate that ghrelin
Physiological functions of ghrelin
Because GHSs, originally developed as activators of GH release, are agonists of the GHS-R, it was reasonable to expect that ghrelin, the endogenous ligand of GHS-R, possesses GH-releasing activity. In fact, ghrelin stimulates GH release from primary pituitary cells in a dose-dependent manner 6. This fact also indicates that ghrelin acts directly on the pituitary. This stimulation is specific; in vitro assays of pituitary cells have demonstrated that ghrelin does not stimulate the secretion of
Conclusion and prospects
In addition to the GHRH pathway, the first report of a GHS about 20 years ago introduced a new regulatory pathway for GH release. Since then, many potent GHSs have been developed, and the structure of the GHS-R has been identified. However, in spite of intensive research, until recently the identity of the endogenous ligand of the GHS-R remained elusive. The discovery of this peptide ligand, ghrelin, opens up a new area for clinical and basic GH research. The structure of ghrelin, and the
References (38)
A new orphan receptor involved in pulsatile growth hormone release
Trends Endocrinol. Metab.
(1999)Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
Brain Res. Mol. Brain Res.
(1997)Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
Cell
(1998)Functional genomics: the search for novel neurotransmitters and neuropeptides
FEBS Lett.
(1998)Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins
Biochim. Biophys. Act.
(1999)Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors
Genomics
(1997)Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor
J. Biol. Chem.
(2000)Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats
Biochem. Biophys. Res. Commun.
(2000)Ghrelin stimulates gastric acid secretion and motility in rats
Biochem. Biophys. Res. Commun.
(2000)Molecular mechanism of growth hormone action
Annu. Rev. Physiol.
(1996)